20th Mar 2008 15:35
ABCAM Plc20 March 2008 For immediate release 20 March 2008 ABCAM PLC ("Abcam" or "the Company") Transfer of Shares Cambridge UK, 20 March 2008: Abcam announces that on 19 March 2008 TonyKouzarides, non-executive director of the Company, transferred 84,836 ordinaryshares of 1p each to his ex-wife at a value of 353 pence per share. Followingthis transfer of shares, Mr Kouzarides has an interest of 114,244 ordinaryshares representing approximately 0.33% of the Company's share capital. For further information please contact: Abcam + 44 (0) 1223 696000Jonathan Milner, Chief Executive OfficerJeff Iliffe, Chief Financial Officerwww.abcam.com Numis Securities + 44 (0) 207260 1000James Black / Nick Westlake Buchanan Communications + 44 (0) 207466 5000Mark Court / Mary-Jane Johnson Notes for editors: About Abcam plc Abcam is a producer and distributor of research-grade antibodies headquarteredin Cambridge, UK, with a US office located in Cambridge, Massachusetts and aJapanese office in Tokyo. Abcam was admitted to AIM in November 2005 and tradesunder the ticker symbol ABC. The Company produces and distributes its own andthird party produced antibodies to academic and commercial users throughout theworld with product information provided and ordering available through theCompany's website, www.abcam.com. The antibodies are sold under the Abcam brandname. The Company's vision is to build the largest online antibody resource inthe world while also ensuring that the antibodies are of high quality andcommercially viable. Abcam now has an online catalogue of approximately 41,000products, most of which are antibodies, from over 200 suppliers supported byup-to-date and detailed technical data sheets, which are created by the Company.The Company currently employs 168 staff in its three operating companies. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
ABC.L